Sérgia Velho

Citado por

	Total	Desde 2019
Citas	2857	1043
Índice h	23	17
Índice i10	35	22

400

200

100

300

200620072008200920102011201220132014201520162017201820192020202120222023202424 51 77 105 134 163 152 177 145 390 132 121 121 120 133 209 256 226 96

Acceso público

Ver todo

17 artículos

4 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Raquel SerucaProfessora da Fac. de Medicina, IpatimupDirección de correo verificada de ipatimup.pt
Carla OliveiraInstitute of Molecular Pathology and Immunology of the University of Porto - IpatimupDirección de correo verificada de ipatimup.pt
Fátima CarneiroProfessora de Medicina, Faculdade de MedicinaDirección de correo verificada de ipatimup.pt
simo schwartz JrVall d'Hebron Hospital Barcelona CampusDirección de correo verificada de vhir.org
Giovanni Corso MD PhDEuropean Institute of Oncology, University of Milan, Milan, ItalyDirección de correo verificada de ieo.it
Catia MoutinhoCEO at The Single-Cell WorldDirección de correo verificada de thesinglecellworld.com
Ana M. FerreiraUniversity Medical Centre GroningenDirección de correo verificada de umcg.nl
Jose Carlos Machadoi3s, IPATIMUP, Universidade do Porto, PortugalDirección de correo verificada de ipatimup.pt
Paula SoaresUniversity of Porto, Medical FacultyDirección de correo verificada de ipatimup.pt
Franco RovielloProfessor of Surgery, University of SienaDirección de correo verificada de unisi.it
Enric DomingoDepartment of Oncology, University of OxfordDirección de correo verificada de oncology.ox.ac.uk
Joana FigueiredoInstituto de Investigação e Inovação em Saúde, Universidade do PortoDirección de correo verificada de ipatimup.pt
Fernando SchmittIPATIMUP and Medical Faculty of Porto UniversityDirección de correo verificada de ipatimup.pt
Corrado PedrazzaniUniversity of VeronaDirección de correo verificada de univr.it
Paulo MatosInstituto Nacional de Saúde Doutor Ricardo Jorge; BioISI - Faculty of Sciences, U. LisboaDirección de correo verificada de insa.min-saude.pt
Carlos F. GuimarãesPhD, 3B's Research GroupDirección de correo verificada de alunos.uminho.pt
Isabel Pereira-Castroi3S/IBMC - University of PortoDirección de correo verificada de ibmc.up.pt
Vitor TroviscoResearch Associate, FlyBase/University of CambridgeDirección de correo verificada de cam.ac.uk
Valdemar Máximoi3s, IPATIMUP, FMUP, Universidade do Porto, PortugalDirección de correo verificada de ipatimup.pt
Manuel Sobrinho-SimõesMedical Faculty of University of PortoDirección de correo verificada de ipatimup.pt

Seguir

Sérgia Velho

IPATIMUP, Porto, Portugal

Dirección de correo verificada de ipatimup.pt

colorectal cancer tumor microenvironment kras braf cancer-associated fibroblasts


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
The prevalence of PIK3CA mutations in gastric and colon cancer S Velho, C Oliveira, A Ferreira, AC Ferreira, G Suriano, S Schwartz Jr, ... European journal of cancer 41 (11), 1649-1654, 2005	479	2005
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression C Oliveira, S Velho, C Moutinho, A Ferreira, A Preto, E Domingo, ... Oncogene 26 (1), 158-163, 2007	282	2007
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis? S Velho, C Moutinho, L Cirnes, C Albuquerque, R Hamelin, F Schmitt, ... BMC cancer 8, 1-6, 2008	257	2008
Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status C Oliveira, JL Westra, D Arango, M Ollikainen, E Domingo, A Ferreira, ... Human molecular genetics 13 (19), 2303-2311, 2004	239	2004
Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies AC Marques, PJ Costa, S Velho, MH Amaral Journal of Controlled Release 320, 180-200, 2020	209	2020
KRAS oncogenic signaling extends beyond cancer cells to orchestrate the microenvironment P Dias Carvalho, CF Guimaraes, AP Cardoso, S Mendonca, AM Costa, ... Cancer research 78 (1), 7-14, 2018	168	2018
Oncogenic mutations in gastric cancer with microsatellite instability G Corso, S Velho, J Paredes, C Pedrazzani, D Martins, F Milanezi, ... European Journal of Cancer 47 (3), 443-451, 2011	120	2011
Molecular and genotypic characterization of human thyroid follicular cell carcinoma–derived cell lines AM Meireles, A Preto, AS Rocha, AP Rebocho, V Máximo, ... Thyroid 17 (8), 707-715, 2007	104	2007
Causes and consequences of microsatellite instability in gastric carcinogenesis S Velho, MS Fernandes, M Leite, C Figueiredo, R Seruca World Journal of Gastroenterology: WJG 20 (44), 16433, 2014	92	2014
B-RafV600E cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival P Matos, C Oliveira, S Velho, V Gonçalves, LT Da Costa, MP Moyer, ... Gastroenterology 135 (3), 899-906, 2008	88	2008
Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progression Y Wang, S Velho, E Vakiani, S Peng, AJ Bass, GC Chu, J Gierut, ... Cancer discovery 3 (3), 294-307, 2013	78	2013
Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer C Oliveira, S Velho, E Domingo, A Preto, RMW Hofstra, R Hamelin, ... Oncogene 24 (51), 7630-7634, 2005	70	2005
BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF^V600E but not KRAS mutations A Preto, J Figueiredo, S Velho, AS Ribeiro, P Soares, C Oliveira, ... The Journal of pathology 214 (3), 320-327, 2008	68	2008
Stimuli-responsive hydrogels for intratumoral drug delivery AC Marques, PJ Costa, S Velho, MH Amaral Drug Discovery Today 26 (10), 2397-2405, 2021	56	2021
Evidence of tumor microsatellite instability in gastric cancer with familial aggregation C Pedrazzani, G Corso, S Velho, M Leite, V Pascale, F Bettarini, ... Familial cancer 8, 215-220, 2009	53	2009
High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability V Davalos, H Dopeso, S Velho, AM Ferreira, L Cirnes, N Diaz-Chico, ... Oncogene 26 (2), 308-311, 2007	53	2007
Targeting the tumor microenvironment: an unexplored strategy for mutant KRAS tumors P Dias Carvalho, AL Machado, F Martins, R Seruca, S Velho Cancers 11 (12), 2010, 2019	45	2019
Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells H Alazzouzi, G Suriano, A Guerra, A Plaja, E Espín, M Armengol, ... Journal of medical genetics 44 (1), 75-80, 2007	35	2007
The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment AP Cardoso, ML Pinto, F Castro, ÂM Costa, A Marques-Magalhaes, ... Cytokine & Growth Factor Reviews 60, 107-119, 2021	33	2021
Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours S Velho, C Oliveira, J Paredes, S Sousa, M Leite, P Matos, F Milanezi, ... Human molecular genetics 19 (4), 697-706, 2010	31	2010

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores